517 related articles for article (PubMed ID: 31013716)
21. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
Fredolini C; Liotta LA; Petricoin EF
Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
[TBL] [Abstract][Full Text] [Related]
22. Urine biomarkers in prostate cancer.
Ploussard G; de la Taille A
Nat Rev Urol; 2010 Feb; 7(2):101-9. PubMed ID: 20065953
[TBL] [Abstract][Full Text] [Related]
23. Promise and challenge: Markers of prostate cancer detection, diagnosis and prognosis.
Troyer DA; Mubiru J; Leach RJ; Naylor SL
Dis Markers; 2004; 20(2):117-28. PubMed ID: 15322319
[TBL] [Abstract][Full Text] [Related]
24. New biomarkers in prostate cancer.
Crawford ED; Ventii K; Shore ND
Oncology (Williston Park); 2014 Feb; 28(2):135-42. PubMed ID: 24701701
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers of Aggressive Prostate Cancer at Diagnosis.
Boehm BE; York ME; Petrovics G; Kohaar I; Chesnut GT
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768533
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Role of RNA Expression Molecular Biomarkers in Prostate and Bladder Cancers.
Ahmed ME; Todenhöfer T; Karnes RJ; Seiler R
Eur Urol Focus; 2022 May; 8(3):663-666. PubMed ID: 35843864
[TBL] [Abstract][Full Text] [Related]
27. Prognostic and predictive biomarkers in prostate cancer.
Kontos CK; Adamopoulos PG; Scorilas A
Expert Rev Mol Diagn; 2015; 15(12):1567-76. PubMed ID: 26548550
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers for evaluation of prostate cancer prognosis.
Esfahani M; Ataei N; Panjehpour M
Asian Pac J Cancer Prev; 2015; 16(7):2601-11. PubMed ID: 25854335
[TBL] [Abstract][Full Text] [Related]
29. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.
Filella X; Foj L
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792187
[TBL] [Abstract][Full Text] [Related]
30. [Tissue biomarkers in prostate cancer.].
Álvarez Múgica M; Jalón Monzón A
Arch Esp Urol; 2022 Mar; 75(2):185-194. PubMed ID: 35332888
[TBL] [Abstract][Full Text] [Related]
31. Prostate Cancer Liquid Biopsy Biomarkers' Clinical Utility in Diagnosis and Prognosis.
Matuszczak M; Schalken JA; Salagierski M
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282798
[TBL] [Abstract][Full Text] [Related]
32. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
[TBL] [Abstract][Full Text] [Related]
33. Novel Diagnostic Biomarkers of Prostate Cancer: An Update.
Anceschi U; Tuderti G; Lugnani F; Biava PM; Malossini G; Luciani L; Cai T; Marsiliani D; Filianoti A; Mattevi D; Costantini M; Misuraca L; Simone G
Curr Med Chem; 2019; 26(6):1045-1058. PubMed ID: 30215331
[TBL] [Abstract][Full Text] [Related]
34. The Use of Biomarkers in Prostate Cancer Screening and Treatment.
Alford AV; Brito JM; Yadav KK; Yadav SS; Tewari AK; Renzulli J
Rev Urol; 2017; 19(4):221-234. PubMed ID: 29472826
[TBL] [Abstract][Full Text] [Related]
35. Tumour markers in prostate cancer: The post-prostate-specific antigen era.
Garrido MM; Bernardino RM; Marta JC; Holdenrieder S; Guimarães JT
Ann Clin Biochem; 2022 Jan; 59(1):46-58. PubMed ID: 34463154
[TBL] [Abstract][Full Text] [Related]
36. Genomic Predictors of Outcome in Prostate Cancer.
Boström PJ; Bjartell AS; Catto JW; Eggener SE; Lilja H; Loeb S; Schalken J; Schlomm T; Cooperberg MR
Eur Urol; 2015 Dec; 68(6):1033-44. PubMed ID: 25913390
[TBL] [Abstract][Full Text] [Related]
37. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
[TBL] [Abstract][Full Text] [Related]
38. Liquid biomarkers for early detection of prostate cancer and summary of available data for their use in African-American men.
Henning GM; Andriole GL; Kim EH
Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):180-186. PubMed ID: 35246608
[TBL] [Abstract][Full Text] [Related]
39. Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature Review.
Sanguedolce F; Cormio A; Brunelli M; D'Amuri A; Carrieri G; Bufo P; Cormio L
Clin Genitourin Cancer; 2016 Apr; 14(2):117-21. PubMed ID: 26774207
[TBL] [Abstract][Full Text] [Related]
40. Molecular diagnosis of prostate cancer: are we up to age?
Bhavsar T; McCue P; Birbe R
Semin Oncol; 2013 Jun; 40(3):259-75. PubMed ID: 23806492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
